结肠直肠癌化学预防加速和改进平台 (CRC-CHAMP) - 队列描述
Darren R Brenner1,2, Xuanhao Feng3, Courtney Maxwell3
1Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Cancer control : journal of the Moffitt Cancer Center
|January 9, 2026
概括
这项试点研究发现,患者对每日低剂量阿司匹林用于结直肠癌化学预防的坚持度很高. 结肠直肠癌化疗预防加速平台 (CRC-CHAMP) 证明了实际干预的可行性.
科学领域:
- 在瘤学瘤学.
- 预防医学 预防医学
- 临床试验 临床试验
背景情况:
- 化学预防剂 (CPA) 为癌症预防提供了一个有希望的策略.
- 患者遵守CPA对于有效的癌症预防至关重要,但需要进一步调查.
- 具有高风险腺瘤息肉病史的个人是结直肠癌 (CRC) 化疗预防的候选人.
研究的目的:
- 通过使用结直肠癌化学预防加速平台 (CRC-CHAMP) 评估真实世界CPA干预的可行性.
- 在一项试点研究中,检查患者招募,吸收和坚持用于CRC化学预防的乙酸 (ASA).
主要方法:
- 一个单臂前性试点研究 (NCT05402124) 涉及50-59岁的个体,最近患有高风险腺多.
- 参与者每天接受81毫克的开放式乙盐酸 (ASA),持续90天.
- 每隔30天,通过电话监测依从性;不良事件是次要结果.
主要成果:
- 招募了67名参与者,其坚持率很高:在30天后89.6%,60天后80.6%,90天后82.1%.
- 13.4%的参与者报告了可能与ASA无关的轻微不良事件.
- 招聘的挑战包括邮件回复率低和先前存在的非类固醇抗炎药物使用.
结论:
- 在CRC-CHAMP试点研究中,患者在90天的时间内高度坚持ASA化疗,副作用最小.
- 这些发现表明,多斑切除术后的个体对CRC化疗预防干预措施敏感.
- 这项研究为未来对癌症预防治疗干预措施的评估提供了框架.
更多相关视频
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.8K
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
637
相关概念视频
02:59Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:07Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:11Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K